Enovis Corp. (CFX)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Enovis Corp. (CFX)
Company Performance

Current Price

as of Oct 16, 2024

$40.78

P/E Ratio

N/A

Market Cap

$2.28B

Description

Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.

Metrics

Overview

  • HQWilmington, DE
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerCFX
  • Price$40.78+2.39%

Trading Information

  • Market Cap$2.28B
  • Float98.74%
  • Average Daily Volume (1m)687,714
  • Average Daily Volume (3m)636,820
  • EPS-$1.94

Company

  • Revenue$1.91B
  • Rev Growth (1yr)22.56%
  • Net Income-$18.57M
  • Gross Margin47.21%
  • EBITDA Margin9.30%
  • EBITDA$48.82M
  • EV$3.86B
  • EV/Revenue2.02
  • P/EN/A
  • P/S1.17
  • P/B0.68